Rapid Visual Detection of Hepatitis C Virus Using Reverse Transcription Recombinase-Aided Amplification–Lateral Flow Dipstick

Recombinase Polymerase Amplification
DOI: 10.3389/fcimb.2022.816238 Publication Date: 2022-02-17T10:47:20Z
ABSTRACT
Hepatitis C virus (HCV) infection is a global public health threat. Reaching the World Health Organization’s objective for eliminating viral hepatitis by 2030 will require precise disease diagnosis. While immunoassays and qPCR play significant role in detecting HCV, rapid accurate point-of-care testing important pathogen identification. This study establishes reverse transcription recombinase-aided amplification–lateral flow dipstick (RT-RAA-LFD) assay to detect HCV. The intact workflow was completed within 30 min, detection limit synthesized C/E1 plasmid gene-containing 10 copies/μl. In addition, test showed good specificity, with no cross-reactivity observed A virus, B HIV, syphilis, human papillomavirus virus. Using extracted RNAs from 46 anti-HCV antibody-positive samples, RT-RAA-LFD 100% positive negative concordance rates qPCR. summary, established this suitable clinical of HCV at community level remote areas.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (20)